Single-phase multislice CT aids pancreatic cancer detection

Article

Multislice CT scanning with contrast enhancement can accurately detect pancreatic cancer in just one pass, according to an Italian study published in the April issue of the American Journal of Roentgenology. It can also identify candidates for surgical resection.

Multislice CT scanning with contrast enhancement can accurately detect pancreatic cancer in just one pass, according to an Italian study published in the April issue of the American Journal of Roentgenology. It can also identify candidates for surgical resection.

Dual-phase helical CT can help physicians diagnose and stage pancreatic malignancies accurately. But it is not as helpful in predicting which lesions could be surgically removed to boost survival. Patients frequently present with advanced disease at the time of diagnosis, and their chances for curative resection drop accordingly.

Dr. Massimo Imbriaco, a radiologist at the University Federico II of Naples, described in 2002 how a single-phase scan-performed in the opposite direction of standard protocols-could provide superior diagnostic accuracy compared with biphasic scanning. This technique was validated only on single-slice CT, however.

Imbriaco and colleagues have since performed single-phase MSCT scanning with contrast in 71 patients with suspected pancreatic carcinoma. They found the new protocol provided accurate diagnosis faster and less expensively than the dual-phase approach, with a lower radiation burden. They also found single-phase MSCT useful in identifying candidates for surgical resection.

A single-phase MSCT acquisition in caudocranial mode might become an alternative to standard dual-phase protocols, the investigators said.

Two experienced abdominal radiologists read the scans independently and at random. They characterized pancreatic lesions and determined their viability for resection. Tumor diagnosis using the proposed protocol provided sensitivities of 95% and 94% and specificities of 93% and 90% for the two reviewers.

The same parameters used in the assessment of tumor resection recorded sensitivities of 94% and 89% and specificities of 90% and 78%. Differences in the compared interpretative results between the two radiologists were not statistically significant.

The data acquisition protocol included caudocranial scanning from the inferior margin of the liver to the diaphragm at 4 x 1-mm slice thickness, 1.25-mm reconstruction interval, 120 kVp and 260 to 280-mAs, pitch 1, and a scanning delay of 60 seconds after contrast injection. Researchers used dedicated software/hardware for image interpretation with a volume rendering technique.

Earlier trials using dual-phase scanning had found that MSCT improved early detection and accurate staging of pancreatic cancer through greater parenchymal, arterial, and portal venous enhancement. The Italian study validates these findings but also finds advantages in single-phase over dual-phase imaging in terms of cost-effectiveness and ease of implementation.

The study had several limitations. Radiation dosage did not consider patients' physiologic differences. A 60-second scanning delay after IV injection may not be ideal for detection of hypervascular pancreatic tumors. And the sample of malignancies was too small.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.